Abeona Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Abeona Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ABEO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000318306
Board of directors
-
Bernhardt G. Zeiher · DirectorSince 2024
-
Christine Berni Silverstein · DirectorSince 2023
-
Donald A. Wuchterl · DirectorSince 2023
-
Eric Crombez · DirectorSince 2024
-
Faith L. Charles · DirectorSince 2023
-
Leila Alland · DirectorSince 2023
-
Mark Alvino · DirectorSince 2023
-
Michael Amoroso · DirectorSince 2023
-
Vishwas Seshadri · Director · Chief Executive OfficerSince 2023
Chief executives
Vishwas Seshadri
· Chief Executive Officer
Dates unknown
Board connections
3 of this board's directors also sit on 5 other boards.
- via Bernhardt G. Zeiher
- via Faith L. Charles
- via Faith L. Charles
- via Bernhardt G. Zeiher
- via Michael Amoroso
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 31, 2025 | Vishwas Seshadri Director, Officer (Chief Executive Officer) | Open-market sale | −25,000 | $4.78 | $119,500 |
| Mar 14, 2025 | Joseph Walter Vazzano Officer (Chief Financial Officer) | Shares withheld for tax | −685 | $5.29 | $3,624 |
| Mar 3, 2025 | O'Malley Brendan M. Officer (SVP, General Counsel) | Shares withheld for tax | −181 | $5.24 | $948 |
| Jan 31, 2025 | Mark Alvino Director | Grant or award | +36,101 | — | — |
| Jan 31, 2025 | Faith L. Charles Director | Grant or award | +36,101 | — | — |
| Jan 31, 2025 | Michael Amoroso Director | Grant or award | +36,101 | — | — |
| Jan 31, 2025 | Eric Crombez Director | Grant or award | +36,101 | — | — |
| Jan 31, 2025 | Leila Alland Director | Grant or award | +36,101 | — | — |
| Jan 31, 2025 | Christine Berni Silverstein Director | Grant or award | +36,101 | — | — |
| Jan 31, 2025 | Bernhardt G. Zeiher Director | Grant or award | +36,101 | — | — |
| Jan 31, 2025 | Donald A. Wuchterl Director | Grant or award | +36,101 | — | — |
| Jan 29, 2025 | Mark Alvino Director | Open-market sale | −4,000 | $5.38 | $21,520 |
| Jan 21, 2025 | O'Malley Brendan M. Officer (SVP, General Counsel) | Grant or award | +115,607 | — | — |
| Jan 21, 2025 | Joseph Walter Vazzano Officer (Chief Financial Officer) | Grant or award | +144,509 | — | — |
| Jan 21, 2025 | Vishwas Seshadri Director, Officer (Chief Executive Officer) | Grant or award | +476,435 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.